Related Experiment Video
Updated: Jul 19, 2025
The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
Epitope mapping of Acinetobacter baumannii outer membrane protein W (OmpW) and laboratory study of an OmpW-derivative
Hana Heidarinia1, Elahe Tajbakhsh1, Mosayeb Rostamian2
1Department of Microbiology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Abstract:
Outer membrane protein W (OmpW) is a less-known A. baumannii antigen with potential immunogenic properties. The epitopes of this protein are not well-identified yet. Therefore, in the present study, B- and T-cell epitopes of A. baumannii OmpW were found using comprehensive in silico and partially in vitro studies. The T-cell (both class-I and class-II) and B-cell (both linear and conformational) epitopes were predicted and screened through many bioinformatics approaches including the prediction of IFN-γ production, immunogenicity, toxicity, allergenicity, human similarity, and clustering. A single 15-mer epitopic peptide containing a linear B-cell and both classes of T-cell epitopes were found and used for further assays. For in vitro assays, patient- and healthy control-derived peripheral blood mononuclear cells were stimulated with the 15-mer peptide, Phytohemagglutinin, or medium alone, and cell proliferation and IFN-γ production assays were performed. The bioinformatics studies led to mapping OmpW epitopes and introducing a 15-mer peptide. In vitro assays to some extent showed its potency in cell proliferation but not in IFN-γ induction, although the responses were not very expressive and faced some questions/limitations. In general, in the current study, we mapped the most immunogenic epitopes of OmpW that may be used for future studies and also assayed one of these epitopes in vitro, which was shown to have an immunogenicity potential. However, the induced immune responses were not strong which suggests that the present peptide needs a series of biotechnological manipulations to be used as a potential vaccine candidate. More studies in this field are recommended.
Insights
Researchers identified key immune targets on Outer membrane protein W (OmpW) from *A. baumannii* using computational and lab methods. A specific peptide showed potential immunogenicity, but further development is needed for vaccine use.
Area of Science:
- Immunology
- Microbiology
- Bioinformatics
Background:
- Outer membrane protein W (OmpW) is an understudied antigen of *Acinetobacter baumannii* with potential immunogenic properties.
- Identification and characterization of OmpW epitopes are crucial for developing targeted interventions against *A. baumannii* infections.
Purpose of the Study:
- To comprehensively identify and characterize B-cell and T-cell epitopes of *A. baumannii* OmpW using in silico and in vitro approaches.
- To evaluate the immunogenic potential of a selected OmpW-derived peptide.
Main Methods:
- Extensive bioinformatics analysis for predicting T-cell (class I and II) and B-cell (linear and conformational) epitopes.
- In silico screening for IFN-γ production, immunogenicity, toxicity, allergenicity, and human similarity.
- In vitro assays using peripheral blood mononuclear cells (PBMCs) stimulated with a 15-mer epitopic peptide to assess cell proliferation and IFN-γ production.
Main Results:
- Bioinformatics approaches successfully mapped potential OmpW epitopes, leading to the identification of a single 15-mer peptide containing linear B-cell and both T-cell epitopes.
- In vitro assays indicated that the 15-mer peptide could stimulate cell proliferation to some extent, but did not significantly induce IFN-γ production.
- The observed immune responses in vitro were not robust, suggesting the peptide requires further optimization for vaccine development.
Conclusions:
- This study successfully mapped immunogenic epitopes of OmpW, providing valuable targets for future research.
- A selected 15-mer OmpW peptide demonstrated preliminary immunogenicity potential in vitro, particularly in cell proliferation.
- Further biotechnological modifications are recommended to enhance the immunogenicity of this peptide for potential vaccine candidate development.
